Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
- PMID: 36503206
- PMCID: PMC9845661
- DOI: 10.3350/cmh.2022.0414
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Keywords: Cirrhosis; Elastography; Portal hypertension; Portal pressure; Risk assessment.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment on
-
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.Clin Mol Hepatol. 2023 Jan;29(1):135-145. doi: 10.3350/cmh.2022.0181. Epub 2022 Sep 5. Clin Mol Hepatol. 2023. PMID: 36064306 Free PMC article.
Similar articles
-
Correspondence on Editorial regarding "Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients".Clin Mol Hepatol. 2023 Jan;29(1):188-190. doi: 10.3350/cmh.2022.0408. Epub 2022 Nov 22. Clin Mol Hepatol. 2023. PMID: 36642415 Free PMC article. No abstract available.
-
Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII.Liver Int. 2023 Sep;43(9):1966-1974. doi: 10.1111/liv.15632. Epub 2023 Jun 8. Liver Int. 2023. PMID: 37288716
-
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.Clin Mol Hepatol. 2023 Jan;29(1):135-145. doi: 10.3350/cmh.2022.0181. Epub 2022 Sep 5. Clin Mol Hepatol. 2023. PMID: 36064306 Free PMC article.
-
Evolving portal hypertension through Baveno VII recommendations.Ann Hepatol. 2024 Jan-Feb;29(1):101180. doi: 10.1016/j.aohep.2023.101180. Epub 2023 Nov 19. Ann Hepatol. 2024. PMID: 37984701 Review.
-
Baveno VII - Renewing consensus in portal hypertension.J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30. J Hepatol. 2022. PMID: 35120736 Free PMC article. Review.
Cited by
-
Risk Factors for Progressive Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C in India.Cureus. 2024 Jul 15;16(7):e64550. doi: 10.7759/cureus.64550. eCollection 2024 Jul. Cureus. 2024. PMID: 39144860 Free PMC article.
-
Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases.Cureus. 2024 Feb 14;16(2):e54206. doi: 10.7759/cureus.54206. eCollection 2024 Feb. Cureus. 2024. PMID: 38496121 Free PMC article.
-
Evaluation of Noninvasive Tools for Predicting Esophageal Varices in Patients With Cirrhosis at Tygerberg Hospital, Cape Town.Int J Hepatol. 2024 Sep 11;2024:9952610. doi: 10.1155/2024/9952610. eCollection 2024. Int J Hepatol. 2024. PMID: 39296589 Free PMC article.
-
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis.World J Gastroenterol. 2024 Feb 21;30(7):685-704. doi: 10.3748/wjg.v30.i7.685. World J Gastroenterol. 2024. PMID: 38515952 Free PMC article.
References
-
- Myers JD, Taylor WJ. Occlusive hepatic venous catheterization in the study of the normal liver, cirrhosis of the liver and noncirrhotic portal hypertension. Circulation. 1956;13:368–380. - PubMed
-
- Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis. 2005;37:601–608. - PubMed
-
- Viallet A, Joly JG, Marleau D, Lavoie P. Comparison of free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver. Gastroenterology. 1970;59:372–375. - PubMed
-
- Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–488. - PubMed
-
- Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical